Allurion Technologies Inc. – NYSE:ALUR

Add to watchlist

$2.26

+1.82

+419.78%

Market open

Closed in about 4 hours

-58.96%

month

-58.96%

quarter

-88.40%

year

Market Cap	22.94M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-3.67

Revenue	48.78M
EBITDA	-75.46M
Income	-57.22M
Revenue Q/Q	-33.29%
Revenue Y/Y	-25.60%

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	-154.7%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Allurion Technologies Inc. (NYSE:ALUR): Profit margin
Jun 2023	12.96M	-21.99M	-169.72%
Sep 2023	18.2M	-21.63M	-118.85%
Dec 2023	8.23M	-19.18M	-232.91%
Mar 2024	9.38M	5.58M	59.51%

Allurion Technologies Financials Estimate

Q Y

Allurion Technologies Inc. (NYSE:ALUR): Analyst Estimates
Dec 2023	8.23M	-19.18M	-232.91%
Mar 2024	9.38M	5.58M	59.51%
Sep 2025	20.9M	-4.42M	-21.18%
Dec 2025	20.5M	-3.93M	-19.2%

Analysts Price target
Financials & Ratios estimates

Allurion Technologies Inc. (NYSE:ALUR): Earnings per share (EPS)
2024-03-21	-0.51	-0.63
2024-05-14	-0.3	0.11

Allurion Technologies Inc. (NYSE:ALUR): Debt to assets
Jun 2023	52151000	162.49M	311.58%
Sep 2023	120688000	173.44M	143.71%
Dec 2023	71712000	142.19M	198.29%
Mar 2024	59988000	126.15M	210.29%

Allurion Technologies Inc. (NYSE:ALUR): Cash Flow
Jun 2023	-9.69M	-131K	4.64M
Sep 2023	-23.09M	-800K	98.88M
Dec 2023	-20.87M	-398K	-20.40M
Mar 2024	-8.63M	-104K	387K

Allurion Technologies alternative data

Allurion Technologies
Employees

Allurion Technologies Inc. (NYSE:ALUR): Employee count
Dec 2023	268
Jan 2024	268
Feb 2024	268
Mar 2024	268
Apr 2024	501
May 2024	501
Jun 2024	501
Jul 2024	501

Allurion Technologies
Earnings Call Transcripts

Quarter	Transcript
Q1 2024 14 May 2024	Q1 2024 Earnings Call Transcript
Q4 2023 21 Mar 2024	Q4 2023 Earnings Call Transcript
Q3 2023 17 Nov 2023	Q3 2023 Earnings Call Transcript

ALUR earnings call transcripts

Allurion Technologies
Latest News

Tuesday, 24 December 2024
07:00	Allurion Technologies, Inc. Announces Reverse Stock Split	businesswire.com
Monday, 2 December 2024
08:00	Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance	businesswire.com
Monday, 25 November 2024
08:00	Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program	businesswire.com
Wednesday, 13 November 2024
12:43	Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript	seekingalpha.com
Wednesday, 30 October 2024
08:30	Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024	businesswire.com
Thursday, 24 October 2024
13:56	ALUR Stock Declines Despite Submitting PMA for Allurion Balloon	zacks.com
Wednesday, 9 October 2024
13:46	October's 4 Best Penny Stocks: High-Risk, High-Reward Picks	benzinga.com
Friday, 4 October 2024
09:27	October's 4 Best Penny Stocks: High-Risk, High-Reward Picks	marketbeat.com
Tuesday, 1 October 2024
08:04	Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss	businesswire.com
Tuesday, 13 August 2024
10:18	Allurion Technologies Inc. (ALUR) Q2 2024 Earnings Call Transcript	seekingalpha.com
Tuesday, 16 July 2024
16:05	Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024	businesswire.com
Wednesday, 26 June 2024
08:36	Allurion Announces Launch of Offering of Common Stock and Warrants	businesswire.com
Thursday, 20 June 2024
15:49	Why Is Allurion (ALUR) Stock Up 140% Today?	investorplace.com
08:00	Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss	businesswire.com
Friday, 14 June 2024
14:46	Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy	zacks.com
Tuesday, 11 June 2024
10:35	Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner	zacks.com
08:00	Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery	businesswire.com
Wednesday, 5 June 2024
08:00	Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer	businesswire.com
Thursday, 30 May 2024
08:00	Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s	businesswire.com
Wednesday, 29 May 2024
16:05	Allurion to Participate in Two Upcoming Investor Conferences in June 2024	businesswire.com
Wednesday, 15 May 2024
08:00	Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss	businesswire.com
Tuesday, 14 May 2024
08:00	Allurion Reports First Quarter 2024 Financial Results and Provides Business Update	businesswire.com
Thursday, 2 May 2024
08:00	Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey	businesswire.com
Tuesday, 30 April 2024
08:30	Allurion Announces Preliminary First Quarter 2024 Results	businesswire.com
Wednesday, 17 April 2024
08:31	Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments	businesswire.com
Thursday, 4 April 2024
14:29	Why Is Allurion (ALUR) Stock Up 65% Today?	InvestorPlace

Frequently Asked Questions (FAQ)

What's the price of Allurion Technologies stock today?

One share of Allurion Technologies stock can currently be purchased for approximately $2.26.
When is Allurion Technologies's next earnings date?

Unfortunately, Allurion Technologies's (ALUR) next earnings date is currently unknown.
Does Allurion Technologies pay dividends?

No, Allurion Technologies does not pay dividends.
How much money does Allurion Technologies make?

Allurion Technologies has a market capitalization of 22.94M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 16.73% to 53.47M US dollars. Allurion Technologies made a loss 82.3M US dollars in net income (profit) last year or $0.11 on an earnings per share basis.
What is Allurion Technologies's stock symbol?

Allurion Technologies Inc. is traded on the NYSE under the ticker symbol "ALUR".
What is Allurion Technologies's primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of Allurion Technologies?

Shares of Allurion Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Allurion Technologies have?

As Jul 2024, Allurion Technologies employs 501 workers.
When Allurion Technologies went public?

Allurion Technologies Inc. is publicly traded company for more then 4 years since IPO on 29 Mar 2021.
What is Allurion Technologies's official website?

The official website for Allurion Technologies is allurion.com.
Where are Allurion Technologies's headquarters?

Allurion Technologies is headquartered at 11 Huron Drive, Natick, MA.
How can i contact Allurion Technologies?

Allurion Technologies's mailing address is 11 Huron Drive, Natick, MA and company can be reached via phone at +508 6474000.

Allurion Technologies Inc.

allurion.com

Exchange:

NYSE

Full time employees:

501

Industry:

Medical - Devices

Sector:

Healthcare

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

+508 6474000

11 Huron Drive
Natick, MA 01760

CIK: 0001964979
ISIN: US02008G1022
CUSIP: 02008G102